Immunalysis develops, manufactures and markets immunoassay reagents for the screening of Drugs of Abuse and other small molecules in a variety of biological matrices. The company draws upon its expertise in organic chemistry, immunology, biochemistry, assay development and quality control, to supply immunoassay reagents and validated automation options.